Key Points University of Queensland researchers are developing a topical cream to prevent and treat skin cancers in transplant patients. $344,000 from the National Foundation for Medical Research and Innovation will support pre-clinical development. The novel drug prevents and treats skin cancer, addressing gaps in existing treatments for squamous cell carcinomas (SCC). QEDDI is refining skin application depth and scaling manufacturing for clinical trials. UniQuest has patented the molecule, ensuring its path to clinical trials. A world-first topical cream designed...